RALEXAR THERAPEUTICS INC has a total of 23 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, EPO (European Patent Office) and Mexico. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are CEPA SCHWARZ PHARMA S L, INST OF MATARIA MEDICA CHINESE and SYNTEX PHARMA LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Mexico | 3 | |
#4 | Israel | 2 | |
#5 | Japan | 2 | |
#6 | Australia | 1 | |
#7 | Hungary | 1 | |
#8 | New Zealand | 1 | |
#9 | Serbia | 1 | |
#10 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Mohan Raju | 16 |
#2 | Raju Mohan | 5 |
Publication | Filing date | Title |
---|---|---|
NZ629636A | Liver x receptor (lxr) modulators for the treatment of dermal diseases, disorders and conditions |